Management of Opioid-Induced Constipation in Patients with Malignancy

Am J Med. 2018 Sep;131(9):1041-1051.e3. doi: 10.1016/j.amjmed.2018.02.038. Epub 2018 Apr 2.

Authors

Jose M Garcia¹, Tatyana A Shamliyan²

Affiliations

¹ Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington School of Medicine, Seattle; Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Wash.
² Quality Assurance, Evidence-Based Medicine Center, Elsevier, Philadelphia, Pa. Electronic address: t.shamliyan@elsevier.com.

PMID: 29621475
DOI: 10.1016/j.amjmed.2018.02.038

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Analgesics, Opioid / adverse effects*
Cancer Pain / drug therapy*
Constipation / chemically induced*
Constipation / therapy*
Enema
Gastrointestinal Agents / therapeutic use
Gastrostomy
Humans
Laxatives / therapeutic use
Morphinans / therapeutic use
Naltrexone / analogs & derivatives
Naltrexone / therapeutic use
Piperidines / therapeutic use
Polyethylene Glycols / therapeutic use
Practice Guidelines as Topic
Quaternary Ammonium Compounds / therapeutic use

Substances

Analgesics, Opioid
Gastrointestinal Agents
Laxatives
Morphinans
Piperidines
Quaternary Ammonium Compounds
naldemedine
methylnaltrexone
Polyethylene Glycols
naloxegol
Naltrexone
alvimopan